Literature DB >> 27198843

Focused cardiac ultrasound screening for rheumatic heart disease by briefly trained health workers: a study of diagnostic accuracy.

Daniel Engelman1, Joseph H Kado2, Bo Reményi3, Samantha M Colquhoun4, Jonathan R Carapetis5, Susan Donath6, Nigel J Wilson7, Andrew C Steer8.   

Abstract

BACKGROUND: Echocardiographic screening for rheumatic heart disease (RHD) can identify individuals with subclinical disease who could benefit from antibiotic prophylaxis. However, most settings have inadequate resources to implement conventional echocardiography and require a feasible, accurate screening method. We aimed to investigate the accuracy of screening by non-expert operators using focused cardiac ultrasound (FoCUS).
METHODS: In this prospective study of diagnostic accuracy, we recruited schoolchildren aged 5 to 15 years in Fiji to undergo two blinded tests. The index test was a FoCUS assessment of mitral and aortic regurgitation, performed by nurses after an 8-week training programme. The reference standard was the diagnosis of RHD by a paediatric cardiologist, based on a standard echocardiogram performed by a skilled echocardiographer. The primary outcome was the accuracy of the index test with use of the most sensitive criteria (any regurgitation).
FINDINGS: We included 2004 children in the study. The index tests were done between September, 2012, and September, 2013, by seven nurses in eight schools in Fiji. The diagnostic accuracy of the screening test (area under receiver operator characteristic curve) was 0·89 (95% CI 0·83-0·94). When the primary cut-off point (any regurgitation) was used for analysis, sensitivity was 84·2% (72·1-92·5) and specificity was 85·6% (83·9-87·1). The sensitivity of individual nurses ranged from 66·7% to 100% and specificity 74·0% to 93·7%.
INTERPRETATION: Screening by briefly trained nurses using FoCUS was accurate for the diagnosis of RHD. Refinements to training and screening test methods should be studied in a range of settings, and in parallel with investigations of the long-term clinical and cost-effectiveness of screening for RHD. FUNDING: Cure Kids, New Zealand; the Fiji Water Foundation provided funding for portable ultrasound equipment; see acknowledgments for further details of funders.
Copyright © 2016 Engelman et al. Open Access article distributed under the terms of CC BY-NC-ND. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27198843     DOI: 10.1016/S2214-109X(16)30065-1

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


  12 in total

1.  Normal echocardiographic mitral and aortic valve thickness in children.

Authors:  Rachel H Webb; Nicola Culliford-Semmens; Karishma Sidhu; Nigel J Wilson
Journal:  Heart Asia       Date:  2017-03-21

2.  Screening-detected rheumatic heart disease can progress to severe disease.

Authors:  Daniel Engelman; Gavin R Wheaton; Reapi L Mataika; Joseph H Kado; Samantha M Colquhoun; Bo Remenyi; Andrew C Steer
Journal:  Heart Asia       Date:  2016-11-28

3.  Inter-rater and intra-rater reliability and agreement of echocardiographic diagnosis of rheumatic heart disease using the World Heart Federation evidence-based criteria.

Authors:  Bo Remenyi; Jonathan Carapetis; John W Stirling; Beatrice Ferreira; Krishnan Kumar; John Lawrenson; Eloi Marijon; Mariana Mirabel; A O Mocumbi; Cleonice Mota; John Paar; Anita Saxena; Janet Scheel; Satu Viali; I B Vijayalakshmi; Gavin R Wheaton; Liesl Zuhlke; Karishma Sidhu; Eliazar Dimalapang; Thomas L Gentles; Nigel J Wilson
Journal:  Heart Asia       Date:  2019-06-24

4.  The clinical characteristics of adults with rheumatic heart disease in Yangon, Myanmar: An observational study.

Authors:  Nan Phyu Sin Toe Myint; Ne Myo Aung; Myint Soe Win; Thu Ya Htut; Anna P Ralph; David A Cooper; Myo Lwin Nyein; Mar Mar Kyi; Josh Hanson
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

5.  Improving health-care delivery in low-resource settings with nanotechnology: Challenges in multiple dimensions.

Authors:  James J Abbas; Barbara Smith; Mladen Poluta; Adriana Velazquez-Berumen
Journal:  Nanobiomedicine (Rij)       Date:  2017-03-29

Review 6.  Rheumatic heart disease: infectious disease origin, chronic care approach.

Authors:  Judith M Katzenellenbogen; Anna P Ralph; Rosemary Wyber; Jonathan R Carapetis
Journal:  BMC Health Serv Res       Date:  2017-11-29       Impact factor: 2.655

7.  The use of focused cardiac ultrasound to screen for occult heart disease in asymptomatic cats.

Authors:  Kerry A Loughran; John E Rush; Elizabeth A Rozanski; Mark A Oyama; Éva Larouche-Lebel; Marc S Kraus
Journal:  J Vet Intern Med       Date:  2019-07-17       Impact factor: 3.333

8.  Prevalence and prognostic value of echocardiographic screening for rheumatic heart disease.

Authors:  Susy Kotit; Karim Said; Amr ElFaramawy; Hani Mahmoud; David I W Phillips; Magdi H Yacoub
Journal:  Open Heart       Date:  2017-12-17

9.  The RECARDINA Study protocol: diagnostic utility of ultra-abbreviated echocardiographic protocol for handheld machines used by non-experts to detect rheumatic heart disease.

Authors:  Joshua Reginald Francis; Helen Fairhurst; Gillian Whalley; Alex Kaethner; Anna Ralph; Jennifer Yan; James Cush; Vicki Wade; Andre Monteiro; Bo Remenyi
Journal:  BMJ Open       Date:  2020-05-27       Impact factor: 2.692

10.  Prevalence of rheumatic heart disease in Zambian school children.

Authors:  John Musuku; Mark E Engel; Patrick Musonda; Joyce Chipili Lungu; Elizabeth Machila; Sherri Schwaninger; Agnes Mtaja; Evans Mulendele; Dorothy Kavindele; Jonathan Spector; Brigitta Tadmor; Marcelo M Gutierrez; Joris Van Dam; Laurence Colin; Aidan Long; Mark C Fishman; Bongani M Mayosi; Liesl J Zühlke
Journal:  BMC Cardiovasc Disord       Date:  2018-07-03       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.